Cheung, WM, Hawkes, A, Ibish, S, Weeks, AD. The retained placenta: historical and geographical rate variations: J Obstet Gynaecol. 2011;31(1):37–42.CrossRefGoogle ScholarPubMed

Sood, M, Khiwal, RP, Sabharwal, A. Management of postpartum haemorrhage. In Desai, P, Malhotra, N, Shah, D (eds.), Principles and Practice of Obstetrics and Gynaecology for Postgraduates. FOGSI Publication. New Delhi: Jaypee Brothers Medical Publishers; 1996, 357–64.Google Scholar

Prendiville, WJ, Elbourne, D, McDonald, S. Active versus expectant management of the third stage of labour. Cochrane Database Syst Rev. 2000;3:CD000007. Update in 2009;3:CD000007.Google Scholar

Abdel-Aleem, H, Abdel-Aleem, MA, Shaaban, OM. Tocolysis for management of retained placenta. Cochrane Database Syst Rev. 2011;1:CD007708.Google Scholar

Pipingas, A, Hofmeyr, GJ, Sesel, KR. Umbilical vessel oxytocin administration for retained placenta: in vitro study of various infusion techniques. Am J Obstet Gynecol. 1993;168:793–5.CrossRefGoogle ScholarPubMed

Bider, D, Dulitzky, M, Goldenberg, M, et al. Intraumbilical vein injection of prostaglandin F2a in retained placenta. Eur J Obstet Gynecol Reprod Biol. 1996;64:59–61.CrossRefGoogle ScholarPubMed

Nardin, JM, Weeks, A, Carroli, G. Umbilical vein injection for management of retained placenta. Cochrane Database Syst Rev. 2011;5:CD001337.Google Scholar

Reyes, FI, Winter, JSD, Falman, C. Postpartum disappearance of chorionic gonadotrophin from the maternal and neonatal circulations. Am J Obstet Gynaecol. 1985;153:486–9.CrossRefGoogle ScholarPubMed

Arulkumaran, S, Ng, CSA, Ingemarsson, I, Ratnam, SS. Medical treatment of placenta accreta with methotrexate. Acta Obstet Gynecol Scand. 1986;65:285–6.CrossRefGoogle ScholarPubMed

Purwar, MB. Injection into umbilical vein for management of retained placenta: RHL practical aspects (last revised: 15 January 2002). The WHO Reproductive Health Library. Geneva: World Health Organization.Google Scholar

Danielsson, KG, Marions, L, Rodriguez, A, et al. Comparison between oral and vaginal administration of misoprostol on uterine contractility. Obstet Gynecol. 1999;93:275–80.Google ScholarPubMed

Alalaf, SK, Al Tawil, NG, Jawad, AK, et al. Umbilical vein injection of 400 versus 800 μg misoprostol for the treatment of retained placenta: a multicenter, randomized double-blind controlled trial. J Obstet Gynaecol Res. 2020 Mar 10. DOI: 10.1111/jog.14232.CrossRefGoogle Scholar

Denison, FC, Carruthers, KF, Hudson, J, et al. Glyceryl trinitrate to reduce the need for manual removal of retained placenta following vaginal delivery: the GOT-IT RCT. Health Technol Assess. 2019 Dec;23(70):1–72. DOI: 10.3310/hta23700.CrossRefGoogle ScholarPubMed

Rottenstreich, M, Rotem, R, Bergman, M, Rottenstreich, A, Grisaru-Granovsky, S. Recurrence of retained placenta in multiple consecutive deliveries. J Matern Fetal Neonatal Med. 2019; Nov 12:1–6. DOI: 10.1080/14767058.2019.1688294.Google Scholar